Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Deconinck

Showing results (81-90 of 136) with videos related to

Pageof 14
Sort By:
Cell|July 13, 2000
FOG-2, a cofactor for GATA transcription factors, is essential for heart morphogenesis and development of coronary vessels from epicardiumS G Tevosian, A E Deconinck, M Tanaka, et al.
Bone Marrow Transplantation|December 2, 2000
Value of autologous stem cell transplantation with purged bone marrow as first-line therapy for follicular lymphoma with high tumor burden: a GOELAMS phase II studyP Colombat, P Cornillet, E Deconinck, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 4, 2003
Early cardiotoxicity of the CHOP regimen in aggressive non-Hodgkin's lymphomaS Limat, K Demesmay, L Voillat, et al.
Development (Cambridge, England)|April 19, 2000
FOG acts as a repressor of red blood cell development in XenopusA E Deconinck, P E Mead, S G Tevosian, et al.
Bone Marrow Transplantation|November 21, 2012
Treatment of adult ALL with central nervous system involvement at diagnosis using autologous and allogeneic transplantation: a study from the Société Française de Greffe de Moelle et de Thérapie CellulaireS P Chantepie, M Mohty, R Tabrizi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 15, 1998
High-dose therapy followed by stem cell transplantation in partial response after first-line induction therapy for aggressive non-Hodgkin's lymphomaC Haioun, E Lepage, C Gisselbrecht, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1995
Herpes virus-related lymphoproliferative disorders following allogeneic bone marrow transplantation: clinical and biological characteristics of six casesA Brion, J Y Cahn, C Mougin, et al.
Journal of Clinical Microbiology|January 14, 2011
Ribosomal and mitochondrial DNA target for real-time PCR diagnosis of invasive aspergillosisL Millon, F Grenouillet, F Legrand, et al.
Leukemia & Lymphoma|November 1, 1993
Graft failure after T cell depleted HLA identical allogeneic bone marrow transplantation: risk factors in leukemic patientsM Delain, J Y Cahn, E Racadot, et al.
Nouvelle Revue Francaise D'Hematologie|December 1, 1994
Role of chemoresistance prior to autologous bone marrow transplantation for Hodgkin's diseaseL Voillat, E Deconinck, M Flesch, et al.
Pageof 14

Showing results (81-90 of 136) with videos related to

Sort By:
Pageof 14
Cell|July 13, 2000
FOG-2, a cofactor for GATA transcription factors, is essential for heart morphogenesis and development of coronary vessels from epicardiumS G Tevosian, A E Deconinck, M Tanaka, et al.
Bone Marrow Transplantation|December 2, 2000
Value of autologous stem cell transplantation with purged bone marrow as first-line therapy for follicular lymphoma with high tumor burden: a GOELAMS phase II studyP Colombat, P Cornillet, E Deconinck, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 4, 2003
Early cardiotoxicity of the CHOP regimen in aggressive non-Hodgkin's lymphomaS Limat, K Demesmay, L Voillat, et al.
Development (Cambridge, England)|April 19, 2000
FOG acts as a repressor of red blood cell development in XenopusA E Deconinck, P E Mead, S G Tevosian, et al.
Bone Marrow Transplantation|November 21, 2012
Treatment of adult ALL with central nervous system involvement at diagnosis using autologous and allogeneic transplantation: a study from the Société Française de Greffe de Moelle et de Thérapie CellulaireS P Chantepie, M Mohty, R Tabrizi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 15, 1998
High-dose therapy followed by stem cell transplantation in partial response after first-line induction therapy for aggressive non-Hodgkin's lymphomaC Haioun, E Lepage, C Gisselbrecht, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1995
Herpes virus-related lymphoproliferative disorders following allogeneic bone marrow transplantation: clinical and biological characteristics of six casesA Brion, J Y Cahn, C Mougin, et al.
Journal of Clinical Microbiology|January 14, 2011
Ribosomal and mitochondrial DNA target for real-time PCR diagnosis of invasive aspergillosisL Millon, F Grenouillet, F Legrand, et al.
Leukemia & Lymphoma|November 1, 1993
Graft failure after T cell depleted HLA identical allogeneic bone marrow transplantation: risk factors in leukemic patientsM Delain, J Y Cahn, E Racadot, et al.
Nouvelle Revue Francaise D'Hematologie|December 1, 1994
Role of chemoresistance prior to autologous bone marrow transplantation for Hodgkin's diseaseL Voillat, E Deconinck, M Flesch, et al.
Pageof 14